

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 5.12702429 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 5.12702429 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.42340726 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 4.42340726 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 4.26547412 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.26547412 |
| 7 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.14417466 |
| 8 | proline biosynthetic process (GO:0006561) | 4.10883174 |
| 9 | proteasome assembly (GO:0043248) | 4.06376342 |
| 10 | regulation of mitochondrial translation (GO:0070129) | 4.06160113 |
| 11 | protein retention in ER lumen (GO:0006621) | 3.87370099 |
| 12 | pseudouridine synthesis (GO:0001522) | 3.86402796 |
| 13 | sulfur amino acid catabolic process (GO:0000098) | 3.84681350 |
| 14 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.79985067 |
| 15 | valine metabolic process (GO:0006573) | 3.69256060 |
| 16 | cysteine metabolic process (GO:0006534) | 3.67167087 |
| 17 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.59348346 |
| 18 | aromatic amino acid family catabolic process (GO:0009074) | 3.54613884 |
| 19 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.53129893 |
| 20 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.51823039 |
| 21 | DNA strand elongation (GO:0022616) | 3.47906415 |
| 22 | mitochondrial calcium ion transport (GO:0006851) | 3.45936058 |
| 23 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.41573784 |
| 24 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.40280432 |
| 25 | alpha-linolenic acid metabolic process (GO:0036109) | 3.37771809 |
| 26 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.37015786 |
| 27 | nucleobase biosynthetic process (GO:0046112) | 3.34920666 |
| 28 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.34353064 |
| 29 | negative regulation of ligase activity (GO:0051352) | 3.34353064 |
| 30 | protein carboxylation (GO:0018214) | 3.30065962 |
| 31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.30065962 |
| 32 | * dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 3.29573716 |
| 33 | positive regulation of nuclease activity (GO:0032075) | 3.28636478 |
| 34 | regulation of translational termination (GO:0006449) | 3.27695526 |
| 35 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.25800256 |
| 36 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.21263022 |
| 37 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.21007686 |
| 38 | response to misfolded protein (GO:0051788) | 3.20561204 |
| 39 | base-excision repair, AP site formation (GO:0006285) | 3.20158697 |
| 40 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.19272319 |
| 41 | cellular modified amino acid catabolic process (GO:0042219) | 3.19249178 |
| 42 | drug transport (GO:0015893) | 3.19022607 |
| 43 | rRNA modification (GO:0000154) | 3.17683818 |
| 44 | 4-hydroxyproline metabolic process (GO:0019471) | 3.16251610 |
| 45 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.15487958 |
| 46 | protein maturation by protein folding (GO:0022417) | 3.15449252 |
| 47 | maturation of 5.8S rRNA (GO:0000460) | 3.14355908 |
| 48 | tricarboxylic acid metabolic process (GO:0072350) | 3.13142283 |
| 49 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.11274239 |
| 50 | mannose metabolic process (GO:0006013) | 3.10910643 |
| 51 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.10333015 |
| 52 | termination of RNA polymerase III transcription (GO:0006386) | 3.09734450 |
| 53 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.09734450 |
| 54 | drug transmembrane transport (GO:0006855) | 3.06959156 |
| 55 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.06045174 |
| 56 | glyoxylate metabolic process (GO:0046487) | 3.05321398 |
| 57 | regulation of cholesterol homeostasis (GO:2000188) | 3.03414228 |
| 58 | regulation of translational fidelity (GO:0006450) | 3.03025176 |
| 59 | purine nucleobase biosynthetic process (GO:0009113) | 3.02213717 |
| 60 | ribosome assembly (GO:0042255) | 3.01920765 |
| 61 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.01109668 |
| 62 | regulation of nuclease activity (GO:0032069) | 2.98705987 |
| 63 | histone arginine methylation (GO:0034969) | 2.98218473 |
| 64 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.97801161 |
| 65 | bile acid biosynthetic process (GO:0006699) | 2.94988829 |
| 66 | establishment of integrated proviral latency (GO:0075713) | 2.94619778 |
| 67 | proline metabolic process (GO:0006560) | 2.94513856 |
| 68 | folic acid metabolic process (GO:0046655) | 2.93211052 |
| 69 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.92573752 |
| 70 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.92573752 |
| 71 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.92357606 |
| 72 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.91476546 |
| 73 | endosome to pigment granule transport (GO:0043485) | 2.91430043 |
| 74 | endosome to melanosome transport (GO:0035646) | 2.91430043 |
| 75 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.90621438 |
| 76 | cellular response to topologically incorrect protein (GO:0035967) | 2.89962670 |
| 77 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.89523747 |
| 78 | cellular response to unfolded protein (GO:0034620) | 2.89264841 |
| 79 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.88808521 |
| 80 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.88808521 |
| 81 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.87702004 |
| 82 | fatty acid beta-oxidation (GO:0006635) | 2.86952303 |
| 83 | indole-containing compound catabolic process (GO:0042436) | 2.86232329 |
| 84 | indolalkylamine catabolic process (GO:0046218) | 2.86232329 |
| 85 | tryptophan catabolic process (GO:0006569) | 2.86232329 |
| 86 | mitochondrial RNA metabolic process (GO:0000959) | 2.86082655 |
| 87 | IMP biosynthetic process (GO:0006188) | 2.85925085 |
| 88 | coenzyme catabolic process (GO:0009109) | 2.85683596 |
| 89 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.85562681 |
| 90 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.85562681 |
| 91 | toxin transport (GO:1901998) | 2.85053277 |
| 92 | pantothenate metabolic process (GO:0015939) | 2.84635778 |
| 93 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.84356540 |
| 94 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.84356540 |
| 95 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.84356540 |
| 96 | ER-nucleus signaling pathway (GO:0006984) | 2.84042240 |
| 97 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.83130782 |
| 98 | purine ribonucleotide transport (GO:0015868) | 2.81791207 |
| 99 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.81341661 |
| 100 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.80687751 |
| 101 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.80687751 |
| 102 | ER overload response (GO:0006983) | 2.80506176 |
| 103 | signal peptide processing (GO:0006465) | 2.80129017 |
| 104 | lysine catabolic process (GO:0006554) | 2.79815942 |
| 105 | lysine metabolic process (GO:0006553) | 2.79815942 |
| 106 | tryptophan metabolic process (GO:0006568) | 2.77835042 |
| 107 | 2-oxoglutarate metabolic process (GO:0006103) | 2.77733757 |
| 108 | pentose-phosphate shunt (GO:0006098) | 2.77290053 |
| 109 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.76668773 |
| 110 | ribosome biogenesis (GO:0042254) | 2.76298695 |
| 111 | fatty acid catabolic process (GO:0009062) | 2.76266115 |
| 112 | establishment of viral latency (GO:0019043) | 2.76007007 |
| 113 | oxidative phosphorylation (GO:0006119) | 2.75361100 |
| 114 | respiratory chain complex IV assembly (GO:0008535) | 2.75280689 |
| 115 | serine family amino acid biosynthetic process (GO:0009070) | 2.74728263 |
| 116 | tRNA aminoacylation (GO:0043039) | 2.74599782 |
| 117 | amino acid activation (GO:0043038) | 2.74599782 |
| 118 | reverse cholesterol transport (GO:0043691) | 2.74571582 |
| 119 | tRNA aminoacylation for protein translation (GO:0006418) | 2.74050896 |
| 120 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.73620469 |
| 121 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.73421951 |
| 122 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.72519160 |
| 123 | deoxyribonucleotide catabolic process (GO:0009264) | 2.71324338 |
| 124 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.71252431 |
| 125 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.71252431 |
| 126 | aromatic amino acid family metabolic process (GO:0009072) | 2.71248458 |
| 127 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.71205533 |
| 128 | fatty acid oxidation (GO:0019395) | 2.70544488 |
| 129 | lipid oxidation (GO:0034440) | 2.70416662 |
| 130 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.69219698 |
| 131 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.68917649 |
| 132 | nuclear envelope reassembly (GO:0031468) | 2.68051346 |
| 133 | mitotic nuclear envelope reassembly (GO:0007084) | 2.68051346 |
| 134 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.67736493 |
| 135 | GDP-mannose metabolic process (GO:0019673) | 2.67703641 |
| 136 | nucleoside salvage (GO:0043174) | 2.66551609 |
| 137 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.66133619 |
| 138 | regulation of cholesterol metabolic process (GO:0090181) | 2.65560366 |
| 139 | deoxyribose phosphate catabolic process (GO:0046386) | 2.65076118 |
| 140 | peptide catabolic process (GO:0043171) | 2.64864274 |
| 141 | DNA replication initiation (GO:0006270) | 2.63915884 |
| 142 | fructose metabolic process (GO:0006000) | 2.62286868 |
| 143 | mitochondrial DNA replication (GO:0006264) | 2.61197618 |
| 144 | cytochrome complex assembly (GO:0017004) | 2.61078522 |
| 145 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.60989842 |
| 146 | monocarboxylic acid catabolic process (GO:0072329) | 2.60215162 |
| 147 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.59652009 |
| 148 | positive regulation of ligase activity (GO:0051351) | 2.59553464 |
| 149 | cellular metabolic compound salvage (GO:0043094) | 2.58830871 |
| 150 | high-density lipoprotein particle remodeling (GO:0034375) | 2.58747319 |
| 151 | telomere maintenance via recombination (GO:0000722) | 2.58356008 |
| 152 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.58047572 |
| 153 | homocysteine metabolic process (GO:0050667) | 2.57690105 |
| 154 | serine family amino acid metabolic process (GO:0009069) | 2.57366642 |
| 155 | UTP biosynthetic process (GO:0006228) | 2.57028329 |
| 156 | DNA unwinding involved in DNA replication (GO:0006268) | 2.55963120 |
| 157 | amino-acid betaine metabolic process (GO:0006577) | 2.55769117 |
| 158 | peptidyl-arginine methylation (GO:0018216) | 2.55745783 |
| 159 | peptidyl-arginine N-methylation (GO:0035246) | 2.55745783 |
| 160 | DNA replication checkpoint (GO:0000076) | 2.55322855 |
| 161 | L-serine metabolic process (GO:0006563) | 2.55033508 |
| 162 | mitochondrial DNA metabolic process (GO:0032042) | 2.54402100 |
| 163 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.53869637 |
| 164 | heparin metabolic process (GO:0030202) | 2.53201336 |
| 165 | heparin biosynthetic process (GO:0030210) | 2.53201336 |
| 166 | rRNA transcription (GO:0009303) | 2.53160822 |
| 167 | phospholipid efflux (GO:0033700) | 2.53149949 |
| 168 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.53112851 |
| 169 | tRNA methylation (GO:0030488) | 2.52991589 |
| 170 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.52900127 |
| 171 | COPII vesicle coating (GO:0048208) | 2.51738433 |
| 172 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.51650973 |
| 173 | bile acid metabolic process (GO:0008206) | 2.51483082 |
| 174 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.50965273 |
| 175 | coenzyme A metabolic process (GO:0015936) | 2.50411595 |
| 176 | NADPH regeneration (GO:0006740) | 2.50221049 |
| 177 | pyrimidine nucleoside salvage (GO:0043097) | 2.50140362 |
| 178 | pyrimidine-containing compound salvage (GO:0008655) | 2.50140362 |
| 179 | rRNA methylation (GO:0031167) | 2.49738894 |
| 180 | purine-containing compound salvage (GO:0043101) | 2.49507868 |
| 181 | oxaloacetate metabolic process (GO:0006107) | 2.49172353 |
| 182 | cellular amino acid catabolic process (GO:0009063) | 2.48727099 |
| 183 | nucleotide salvage (GO:0043173) | 2.48254391 |
| 184 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.48101071 |
| 185 | negative regulation of cholesterol transport (GO:0032375) | 2.47303132 |
| 186 | negative regulation of sterol transport (GO:0032372) | 2.47303132 |
| 187 | aldehyde catabolic process (GO:0046185) | 2.46667864 |
| 188 | branched-chain amino acid metabolic process (GO:0009081) | 2.46420377 |
| 189 | low-density lipoprotein particle remodeling (GO:0034374) | 2.46369020 |
| 190 | organic acid catabolic process (GO:0016054) | 2.46319017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.16926879 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.68835455 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.56295058 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.51809730 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.30340526 |
| 6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.79783266 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.55798503 |
| 8 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.46829546 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.39700899 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.33210235 |
| 11 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.30151455 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.29951168 |
| 13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.28976408 |
| 14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.26339581 |
| 15 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.20928153 |
| 16 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.19980017 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.18154446 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.08623732 |
| 19 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.06282648 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02479264 |
| 21 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.02130973 |
| 22 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.97694991 |
| 23 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.97011088 |
| 24 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.95195819 |
| 25 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.88364614 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.84048306 |
| 27 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.83804734 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.82645600 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82539085 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.81227174 |
| 31 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.80480247 |
| 32 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.77140254 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.77059002 |
| 34 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.75853870 |
| 35 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.74407437 |
| 36 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73083937 |
| 37 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.70349721 |
| 38 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.67766140 |
| 39 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.66737076 |
| 40 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63349851 |
| 41 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.62068593 |
| 42 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.61484149 |
| 43 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.60723748 |
| 44 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.58103936 |
| 45 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.57248140 |
| 46 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.55253282 |
| 47 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.54234502 |
| 48 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.53605336 |
| 49 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.52458998 |
| 50 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.47951539 |
| 51 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47740442 |
| 52 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.47342776 |
| 53 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46526694 |
| 54 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.46098637 |
| 55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.45877539 |
| 56 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.44316990 |
| 57 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.44209127 |
| 58 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.43053060 |
| 59 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.42357248 |
| 60 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.40262166 |
| 61 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.40200248 |
| 62 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.39696161 |
| 63 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.37647401 |
| 64 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36218629 |
| 65 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.31654993 |
| 66 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.31209419 |
| 67 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.31045988 |
| 68 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.30152345 |
| 69 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.29317591 |
| 70 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.28513211 |
| 71 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.26938572 |
| 72 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.26506496 |
| 73 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26046039 |
| 74 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.25423908 |
| 75 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23986616 |
| 76 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.22909313 |
| 77 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.21527488 |
| 78 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.21084087 |
| 79 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.20787533 |
| 80 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.20563482 |
| 81 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.20492399 |
| 82 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.20161895 |
| 83 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19484431 |
| 84 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.18782058 |
| 85 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18355515 |
| 86 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.17518947 |
| 87 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.17472091 |
| 88 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.16866481 |
| 89 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.16838501 |
| 90 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.15968311 |
| 91 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.15963878 |
| 92 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.15127832 |
| 93 | MYC_22102868_ChIP-Seq_BL_Human | 1.14014916 |
| 94 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.13794322 |
| 95 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.13005757 |
| 96 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12648114 |
| 97 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.12368489 |
| 98 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.12276506 |
| 99 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.11347807 |
| 100 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.11283436 |
| 101 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.11164765 |
| 102 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.09636887 |
| 103 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.08949853 |
| 104 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08017179 |
| 105 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.07775735 |
| 106 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.06931665 |
| 107 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06830954 |
| 108 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06133877 |
| 109 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.06118740 |
| 110 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.05814272 |
| 111 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.05765313 |
| 112 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.05639194 |
| 113 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.05288542 |
| 114 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05058586 |
| 115 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.04731199 |
| 116 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04320723 |
| 117 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.03971481 |
| 118 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.03850179 |
| 119 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.03449336 |
| 120 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.03069279 |
| 121 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.03045224 |
| 122 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02685464 |
| 123 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.01608596 |
| 124 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.01349217 |
| 125 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.01260782 |
| 126 | MYB_26560356_Chip-Seq_TH2_Human | 1.01113061 |
| 127 | MAF_26560356_Chip-Seq_TH1_Human | 1.00900132 |
| 128 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.99553598 |
| 129 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99340683 |
| 130 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.98952916 |
| 131 | UTX_26944678_Chip-Seq_JUKART_Human | 0.98898425 |
| 132 | P68_20966046_ChIP-Seq_HELA_Human | 0.97353476 |
| 133 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96897440 |
| 134 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.96623638 |
| 135 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.96595218 |
| 136 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95240148 |
| 137 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.94739103 |
| 138 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.94375337 |
| 139 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.93837145 |
| 140 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93408451 |
| 141 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.92919147 |
| 142 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.90729830 |
| 143 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.88531948 |
| 144 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.87390822 |
| 145 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.87277315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.40048078 |
| 2 | MP0009840_abnormal_foam_cell | 4.23421354 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.84325673 |
| 4 | MP0005360_urolithiasis | 3.70529884 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.70376486 |
| 6 | MP0005365_abnormal_bile_salt | 3.50780647 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 3.45053043 |
| 8 | MP0003111_abnormal_nucleus_morphology | 3.42926940 |
| 9 | MP0010094_abnormal_chromosome_stability | 3.14153075 |
| 10 | MP0003172_abnormal_lysosome_physiology | 3.08391623 |
| 11 | MP0002254_reproductive_system_inflammat | 2.96834195 |
| 12 | MP0005083_abnormal_biliary_tract | 2.91946788 |
| 13 | MP0003195_calcinosis | 2.91842196 |
| 14 | MP0005085_abnormal_gallbladder_physiolo | 2.82606125 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.77649938 |
| 16 | MP0004957_abnormal_blastocyst_morpholog | 2.68203917 |
| 17 | MP0008058_abnormal_DNA_repair | 2.51267598 |
| 18 | MP0003941_abnormal_skin_development | 2.37364624 |
| 19 | MP0008007_abnormal_cellular_replicative | 2.12719109 |
| 20 | MP0008875_abnormal_xenobiotic_pharmacok | 2.11522934 |
| 21 | MP0010329_abnormal_lipoprotein_level | 2.11483973 |
| 22 | MP0008932_abnormal_embryonic_tissue | 2.11007131 |
| 23 | MP0005332_abnormal_amino_acid | 2.10790856 |
| 24 | MP0001666_abnormal_nutrient_absorption | 2.10322530 |
| 25 | MP0009643_abnormal_urine_homeostasis | 1.88791568 |
| 26 | MP0003077_abnormal_cell_cycle | 1.88464949 |
| 27 | MP0003724_increased_susceptibility_to | 1.82508853 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.80922640 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.79885799 |
| 30 | MP0003718_maternal_effect | 1.78173118 |
| 31 | MP0000604_amyloidosis | 1.72855349 |
| 32 | MP0004272_abnormal_basement_membrane | 1.71996142 |
| 33 | MP0005670_abnormal_white_adipose | 1.71432065 |
| 34 | MP0003329_amyloid_beta_deposits | 1.71003551 |
| 35 | MP0002118_abnormal_lipid_homeostasis | 1.66661772 |
| 36 | MP0003656_abnormal_erythrocyte_physiolo | 1.66520069 |
| 37 | MP0005319_abnormal_enzyme/_coenzyme | 1.64285570 |
| 38 | MP0000609_abnormal_liver_physiology | 1.63377374 |
| 39 | MP0009697_abnormal_copulation | 1.62503013 |
| 40 | MP0005257_abnormal_intraocular_pressure | 1.62184360 |
| 41 | MP0005220_abnormal_exocrine_pancreas | 1.61822827 |
| 42 | MP0003279_aneurysm | 1.57073900 |
| 43 | MP0003786_premature_aging | 1.51681439 |
| 44 | MP0004019_abnormal_vitamin_homeostasis | 1.51621214 |
| 45 | MP0003186_abnormal_redox_activity | 1.50676027 |
| 46 | MP0008961_abnormal_basal_metabolism | 1.49029339 |
| 47 | MP0001730_embryonic_growth_arrest | 1.46896515 |
| 48 | MP0001764_abnormal_homeostasis | 1.44446138 |
| 49 | MP0002909_abnormal_adrenal_gland | 1.43875724 |
| 50 | MP0002837_dystrophic_cardiac_calcinosis | 1.41489145 |
| 51 | MP0000490_abnormal_crypts_of | 1.41314865 |
| 52 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.40893945 |
| 53 | MP0005451_abnormal_body_composition | 1.39573385 |
| 54 | MP0001849_ear_inflammation | 1.38111005 |
| 55 | MP0002693_abnormal_pancreas_physiology | 1.37709096 |
| 56 | MP0003566_abnormal_cell_adhesion | 1.37304671 |
| 57 | MP0003252_abnormal_bile_duct | 1.35494083 |
| 58 | MP0002877_abnormal_melanocyte_morpholog | 1.34167638 |
| 59 | MP0008469_abnormal_protein_level | 1.32213997 |
| 60 | MP0004043_abnormal_pH_regulation | 1.32069016 |
| 61 | MP0008260_abnormal_autophagy | 1.30238062 |
| 62 | MP0000013_abnormal_adipose_tissue | 1.30168953 |
| 63 | MP0003183_abnormal_peptide_metabolism | 1.29399850 |
| 64 | MP0000371_diluted_coat_color | 1.24327208 |
| 65 | MP0001944_abnormal_pancreas_morphology | 1.24064575 |
| 66 | MP0000465_gastrointestinal_hemorrhage | 1.22429749 |
| 67 | MP0006035_abnormal_mitochondrial_morpho | 1.21443448 |
| 68 | MP0000685_abnormal_immune_system | 1.21216654 |
| 69 | MP0005636_abnormal_mineral_homeostasis | 1.21131943 |
| 70 | MP0003436_decreased_susceptibility_to | 1.20152153 |
| 71 | MP0009333_abnormal_splenocyte_physiolog | 1.20038301 |
| 72 | MP0002078_abnormal_glucose_homeostasis | 1.18169689 |
| 73 | MP0000313_abnormal_cell_death | 1.14066067 |
| 74 | MP0002419_abnormal_innate_immunity | 1.11787339 |
| 75 | MP0000350_abnormal_cell_proliferation | 1.10457574 |
| 76 | MP0001533_abnormal_skeleton_physiology | 1.09168972 |
| 77 | MP0005408_hypopigmentation | 1.08523274 |
| 78 | MP0005075_abnormal_melanosome_morpholog | 1.07826602 |
| 79 | MP0000015_abnormal_ear_pigmentation | 1.05811249 |
| 80 | MP0009384_cardiac_valve_regurgitation | 1.05695287 |
| 81 | MP0001765_abnormal_ion_homeostasis | 1.05289860 |
| 82 | MP0000598_abnormal_liver_morphology | 1.05164497 |
| 83 | MP0005671_abnormal_response_to | 1.04198555 |
| 84 | MP0002080_prenatal_lethality | 1.03954412 |
| 85 | MP0001756_abnormal_urination | 1.03405461 |
| 86 | MP0001845_abnormal_inflammatory_respons | 1.03067205 |
| 87 | MP0002019_abnormal_tumor_incidence | 1.02168991 |
| 88 | MP0006036_abnormal_mitochondrial_physio | 1.01757623 |
| 89 | MP0005501_abnormal_skin_physiology | 1.01432087 |
| 90 | MP0005000_abnormal_immune_tolerance | 1.00976075 |
| 91 | MP0005025_abnormal_response_to | 1.00567827 |
| 92 | MP0001243_abnormal_dermal_layer | 1.00567413 |
| 93 | MP0001672_abnormal_embryogenesis/_devel | 1.00131821 |
| 94 | MP0005380_embryogenesis_phenotype | 1.00131821 |
| 95 | MP0001853_heart_inflammation | 0.99103029 |
| 96 | MP0009053_abnormal_anal_canal | 0.98153861 |
| 97 | MP0003763_abnormal_thymus_physiology | 0.96990390 |
| 98 | MP0002723_abnormal_immune_serum | 0.96772945 |
| 99 | MP0009763_increased_sensitivity_to | 0.96481043 |
| 100 | MP0002132_abnormal_respiratory_system | 0.96304813 |
| 101 | MP0001881_abnormal_mammary_gland | 0.95508260 |
| 102 | MP0002090_abnormal_vision | 0.94926450 |
| 103 | MP0002060_abnormal_skin_morphology | 0.94908057 |
| 104 | MP0001790_abnormal_immune_system | 0.94778128 |
| 105 | MP0005387_immune_system_phenotype | 0.94778128 |
| 106 | MP0003705_abnormal_hypodermis_morpholog | 0.94253248 |
| 107 | MP0009642_abnormal_blood_homeostasis | 0.93577749 |
| 108 | MP0003315_abnormal_perineum_morphology | 0.93238938 |
| 109 | MP0000678_abnormal_parathyroid_gland | 0.92566222 |
| 110 | MP0001697_abnormal_embryo_size | 0.92481806 |
| 111 | MP0003075_altered_response_to | 0.92042223 |
| 112 | MP0000358_abnormal_cell_content/ | 0.91550614 |
| 113 | MP0000689_abnormal_spleen_morphology | 0.91467217 |
| 114 | MP0004947_skin_inflammation | 0.90669090 |
| 115 | MP0006082_CNS_inflammation | 0.89566062 |
| 116 | MP0002136_abnormal_kidney_physiology | 0.89369520 |
| 117 | MP0001800_abnormal_humoral_immune | 0.89074476 |
| 118 | MP0010030_abnormal_orbit_morphology | 0.88965729 |
| 119 | MP0009785_altered_susceptibility_to | 0.88247300 |
| 120 | MP0005395_other_phenotype | 0.87274613 |
| 121 | MP0008438_abnormal_cutaneous_collagen | 0.86712043 |
| 122 | MP0001835_abnormal_antigen_presentation | 0.86649120 |
| 123 | MP0002420_abnormal_adaptive_immunity | 0.86213550 |
| 124 | MP0003866_abnormal_defecation | 0.86001207 |
| 125 | MP0002933_joint_inflammation | 0.85399627 |
| 126 | MP0004233_abnormal_muscle_weight | 0.85367456 |
| 127 | MP0010307_abnormal_tumor_latency | 0.85196057 |
| 128 | MP0002160_abnormal_reproductive_system | 0.84922748 |
| 129 | MP0009672_abnormal_birth_weight | 0.84567268 |
| 130 | MP0002452_abnormal_antigen_presenting | 0.84380111 |
| 131 | MP0002938_white_spotting | 0.84043171 |
| 132 | MP0003984_embryonic_growth_retardation | 0.83224876 |
| 133 | MP0001819_abnormal_immune_cell | 0.82849351 |
| 134 | MP0010352_gastrointestinal_tract_polyps | 0.81280438 |
| 135 | MP0003868_abnormal_feces_composition | 0.80717461 |
| 136 | MP0001348_abnormal_lacrimal_gland | 0.80422979 |
| 137 | MP0005023_abnormal_wound_healing | 0.78850904 |
| 138 | MP0006054_spinal_hemorrhage | 0.77669123 |
| 139 | MP0001915_intracranial_hemorrhage | 0.77662360 |
| 140 | MP0002396_abnormal_hematopoietic_system | 0.77195398 |
| 141 | MP0002086_abnormal_extraembryonic_tissu | 0.77032427 |
| 142 | MP0002088_abnormal_embryonic_growth/wei | 0.76647119 |
| 143 | MP0001661_extended_life_span | 0.76076201 |
| 144 | MP0002111_abnormal_tail_morphology | 0.74920649 |
| 145 | MP0002722_abnormal_immune_system | 0.74112334 |
| 146 | MP0001216_abnormal_epidermal_layer | 0.73603890 |
| 147 | MP0003303_peritoneal_inflammation | 0.73530415 |
| 148 | MP0005666_abnormal_adipose_tissue | 0.73176530 |
| 149 | MP0000716_abnormal_immune_system | 0.72460658 |
| 150 | MP0003448_altered_tumor_morphology | 0.71742482 |
| 151 | MP0004782_abnormal_surfactant_physiolog | 0.70764200 |
| 152 | MP0005167_abnormal_blood-brain_barrier | 0.69666587 |
| 153 | MP0002398_abnormal_bone_marrow | 0.69332908 |
| 154 | MP0003690_abnormal_glial_cell | 0.69330807 |
| 155 | MP0003011_delayed_dark_adaptation | 0.69181150 |
| 156 | MP0002295_abnormal_pulmonary_circulatio | 0.68825203 |
| 157 | MP0001545_abnormal_hematopoietic_system | 0.68728187 |
| 158 | MP0005397_hematopoietic_system_phenotyp | 0.68728187 |
| 159 | MP0002085_abnormal_embryonic_tissue | 0.67633352 |
| 160 | MP0005384_cellular_phenotype | 0.67325428 |
| 161 | MP0000538_abnormal_urinary_bladder | 0.65988136 |
| 162 | MP0001186_pigmentation_phenotype | 0.65452026 |
| 163 | MP0002653_abnormal_ependyma_morphology | 0.65368046 |
| 164 | MP0009278_abnormal_bone_marrow | 0.64999540 |
| 165 | MP0002075_abnormal_coat/hair_pigmentati | 0.64524523 |
| 166 | MP0002429_abnormal_blood_cell | 0.64391188 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.41496658 |
| 2 | * Type I transferrin isoform profile (HP:0003642) | 4.01250161 |
| 3 | Dysostosis multiplex (HP:0000943) | 3.64862138 |
| 4 | Xanthomatosis (HP:0000991) | 3.49880752 |
| 5 | Reduced antithrombin III activity (HP:0001976) | 3.47489902 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 3.44766341 |
| 7 | Gout (HP:0001997) | 3.43077720 |
| 8 | Hepatic necrosis (HP:0002605) | 3.40406256 |
| 9 | Generalized aminoaciduria (HP:0002909) | 3.36186987 |
| 10 | Abnormality of the intrinsic pathway (HP:0010989) | 3.34842301 |
| 11 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.26485685 |
| 12 | Hepatocellular necrosis (HP:0001404) | 3.26066768 |
| 13 | Hypoglycemic coma (HP:0001325) | 3.24252602 |
| 14 | Microvesicular hepatic steatosis (HP:0001414) | 3.19737447 |
| 15 | Rough bone trabeculation (HP:0100670) | 3.14478348 |
| 16 | Mucopolysacchariduria (HP:0008155) | 3.07768428 |
| 17 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.07768428 |
| 18 | Deep venous thrombosis (HP:0002625) | 3.02411517 |
| 19 | Abnormal number of erythroid precursors (HP:0012131) | 2.92629298 |
| 20 | Hypoplasia of the pons (HP:0012110) | 2.90977562 |
| 21 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.87414525 |
| 22 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.87414525 |
| 23 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.87414525 |
| 24 | Intrahepatic cholestasis (HP:0001406) | 2.87410729 |
| 25 | Microretrognathia (HP:0000308) | 2.85469522 |
| 26 | Ketosis (HP:0001946) | 2.85448263 |
| 27 | Increased cerebral lipofuscin (HP:0011813) | 2.84791717 |
| 28 | Premature rupture of membranes (HP:0001788) | 2.83839988 |
| 29 | Testicular atrophy (HP:0000029) | 2.78989810 |
| 30 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.75323112 |
| 31 | * Nonimmune hydrops fetalis (HP:0001790) | 2.74758879 |
| 32 | Hyperlipoproteinemia (HP:0010980) | 2.74647794 |
| 33 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.73709012 |
| 34 | Hypoglycemic seizures (HP:0002173) | 2.73550447 |
| 35 | Abnormality of the pons (HP:0007361) | 2.67893245 |
| 36 | Hypokinesia (HP:0002375) | 2.67855143 |
| 37 | Vertebral compression fractures (HP:0002953) | 2.63528583 |
| 38 | Abnormality of the common coagulation pathway (HP:0010990) | 2.62750414 |
| 39 | Brushfield spots (HP:0001088) | 2.59015372 |
| 40 | Ketoacidosis (HP:0001993) | 2.58136268 |
| 41 | Late onset (HP:0003584) | 2.57787153 |
| 42 | Abnormal trabecular bone morphology (HP:0100671) | 2.53405980 |
| 43 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.52596933 |
| 44 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.52596933 |
| 45 | Progressive neurologic deterioration (HP:0002344) | 2.51797573 |
| 46 | Abnormality of glycolipid metabolism (HP:0010969) | 2.51687334 |
| 47 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.51687334 |
| 48 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.51687334 |
| 49 | Hyperglycinuria (HP:0003108) | 2.51269464 |
| 50 | Complement deficiency (HP:0004431) | 2.47571979 |
| 51 | Progressive muscle weakness (HP:0003323) | 2.42072632 |
| 52 | Conjugated hyperbilirubinemia (HP:0002908) | 2.40756655 |
| 53 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.40624184 |
| 54 | Multiple enchondromatosis (HP:0005701) | 2.38297409 |
| 55 | Prolonged neonatal jaundice (HP:0006579) | 2.38150988 |
| 56 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.36226680 |
| 57 | Abnormality of purine metabolism (HP:0004352) | 2.35558066 |
| 58 | Selective tooth agenesis (HP:0001592) | 2.33973479 |
| 59 | Hypobetalipoproteinemia (HP:0003563) | 2.33168014 |
| 60 | Methylmalonic aciduria (HP:0012120) | 2.32687725 |
| 61 | Increased serum lactate (HP:0002151) | 2.31639711 |
| 62 | Myocardial infarction (HP:0001658) | 2.30079689 |
| 63 | Hyperbilirubinemia (HP:0002904) | 2.29356367 |
| 64 | Hyperammonemia (HP:0001987) | 2.29207483 |
| 65 | Systemic lupus erythematosus (HP:0002725) | 2.28687757 |
| 66 | Pancytopenia (HP:0001876) | 2.27601272 |
| 67 | Poor head control (HP:0002421) | 2.27198727 |
| 68 | Retinal atrophy (HP:0001105) | 2.27132349 |
| 69 | Prolonged partial thromboplastin time (HP:0003645) | 2.26757563 |
| 70 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.24686852 |
| 71 | Hypoalphalipoproteinemia (HP:0003233) | 2.23329990 |
| 72 | Global brain atrophy (HP:0002283) | 2.22473756 |
| 73 | Thoracic kyphosis (HP:0002942) | 2.22084136 |
| 74 | Sensorimotor neuropathy (HP:0007141) | 2.21872077 |
| 75 | Hypolipoproteinemia (HP:0010981) | 2.19023773 |
| 76 | Symptomatic seizures (HP:0011145) | 2.18126397 |
| 77 | CNS demyelination (HP:0007305) | 2.17490655 |
| 78 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.17351190 |
| 79 | Premature ovarian failure (HP:0008209) | 2.15888300 |
| 80 | Dicarboxylic aciduria (HP:0003215) | 2.15855429 |
| 81 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.15855429 |
| 82 | Epiphyseal stippling (HP:0010655) | 2.15606381 |
| 83 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.15384211 |
| 84 | Abnormality of glycine metabolism (HP:0010895) | 2.15384211 |
| 85 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.15345145 |
| 86 | Trismus (HP:0000211) | 2.10561989 |
| 87 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.08861505 |
| 88 | Abnormality of methionine metabolism (HP:0010901) | 2.07786360 |
| 89 | Protuberant abdomen (HP:0001538) | 2.06921027 |
| 90 | Lactic acidosis (HP:0003128) | 2.05062123 |
| 91 | Spastic paraparesis (HP:0002313) | 2.04418277 |
| 92 | Increased CSF lactate (HP:0002490) | 2.03725249 |
| 93 | Opisthotonus (HP:0002179) | 2.03104745 |
| 94 | Acute encephalopathy (HP:0006846) | 2.03000627 |
| 95 | Agammaglobulinemia (HP:0004432) | 2.00888744 |
| 96 | Abnormality of nucleobase metabolism (HP:0010932) | 1.99675424 |
| 97 | Increased serum pyruvate (HP:0003542) | 1.99606413 |
| 98 | Large for gestational age (HP:0001520) | 1.99168838 |
| 99 | Fat malabsorption (HP:0002630) | 1.99127862 |
| 100 | Asymmetric septal hypertrophy (HP:0001670) | 1.97899797 |
| 101 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.97274550 |
| 102 | Interstitial pulmonary disease (HP:0006530) | 1.96546965 |
| 103 | Albinism (HP:0001022) | 1.95699160 |
| 104 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.95283649 |
| 105 | Dysautonomia (HP:0002459) | 1.94741308 |
| 106 | Abnormality of complement system (HP:0005339) | 1.94242174 |
| 107 | Glomerulonephritis (HP:0000099) | 1.91217629 |
| 108 | Esophageal neoplasm (HP:0100751) | 1.89910769 |
| 109 | Neoplasm of head and neck (HP:0012288) | 1.89910769 |
| 110 | Abnormality of glycolysis (HP:0004366) | 1.89907248 |
| 111 | Redundant skin (HP:0001582) | 1.89843737 |
| 112 | Mitral stenosis (HP:0001718) | 1.89506780 |
| 113 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.89202007 |
| 114 | * Abnormal protein glycosylation (HP:0012346) | 1.89022784 |
| 115 | * Abnormal glycosylation (HP:0012345) | 1.89022784 |
| 116 | * Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.89022784 |
| 117 | * Abnormal protein N-linked glycosylation (HP:0012347) | 1.89022784 |
| 118 | Beaking of vertebral bodies (HP:0004568) | 1.88904125 |
| 119 | Abnormality of the odontoid process (HP:0003310) | 1.87168296 |
| 120 | Mitochondrial inheritance (HP:0001427) | 1.86888173 |
| 121 | Gastrointestinal inflammation (HP:0004386) | 1.85671091 |
| 122 | Secondary amenorrhea (HP:0000869) | 1.84026337 |
| 123 | Cortical visual impairment (HP:0100704) | 1.82626003 |
| 124 | Abnormality of dentin (HP:0010299) | 1.82594390 |
| 125 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.82357238 |
| 126 | Increased muscle lipid content (HP:0009058) | 1.82313054 |
| 127 | Loss of speech (HP:0002371) | 1.82131865 |
| 128 | Increased serum ferritin (HP:0003281) | 1.81251055 |
| 129 | Lipid accumulation in hepatocytes (HP:0006561) | 1.81082741 |
| 130 | Joint stiffness (HP:0001387) | 1.80639245 |
| 131 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.80359814 |
| 132 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.80359814 |
| 133 | Aplastic anemia (HP:0001915) | 1.79353047 |
| 134 | Hypergonadotropic hypogonadism (HP:0000815) | 1.79091183 |
| 135 | Birth length less than 3rd percentile (HP:0003561) | 1.78959609 |
| 136 | Sparse eyelashes (HP:0000653) | 1.78927117 |
| 137 | Neurofibrillary tangles (HP:0002185) | 1.78852845 |
| 138 | Vascular calcification (HP:0004934) | 1.78514821 |
| 139 | Irritability (HP:0000737) | 1.77068929 |
| 140 | Hyperglycemia (HP:0003074) | 1.75847331 |
| 141 | Abnormality of the preputium (HP:0100587) | 1.75251407 |
| 142 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.75129325 |
| 143 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.75085924 |
| 144 | Meckel diverticulum (HP:0002245) | 1.75041977 |
| 145 | Abnormal epiphyseal ossification (HP:0010656) | 1.74402769 |
| 146 | Ocular albinism (HP:0001107) | 1.74249735 |
| 147 | IgG deficiency (HP:0004315) | 1.73970967 |
| 148 | Generalized amyotrophy (HP:0003700) | 1.73185585 |
| 149 | Acute necrotizing encephalopathy (HP:0006965) | 1.72505512 |
| 150 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.72112187 |
| 151 | Abnormal tarsal ossification (HP:0008369) | 1.71834851 |
| 152 | Horseshoe kidney (HP:0000085) | 1.71782289 |
| 153 | Cardiomegaly (HP:0001640) | 1.71283784 |
| 154 | Pancreatitis (HP:0001733) | 1.71106798 |
| 155 | Hypoplasia of the thymus (HP:0000778) | 1.70581898 |
| 156 | Cardiovascular calcification (HP:0011915) | 1.70461968 |
| 157 | * Death in infancy (HP:0001522) | 1.69999572 |
| 158 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.68233960 |
| 159 | Tongue fasciculations (HP:0001308) | 1.67447048 |
| 160 | Abnormality of the ileum (HP:0001549) | 1.65033794 |
| 161 | Squamous cell carcinoma (HP:0002860) | 1.63861276 |
| 162 | Homocystinuria (HP:0002156) | 1.62540805 |
| 163 | Abnormality of homocysteine metabolism (HP:0010919) | 1.62540805 |
| 164 | Petechiae (HP:0000967) | 1.62156166 |
| 165 | Increased hepatocellular lipid droplets (HP:0006565) | 1.61430859 |
| 166 | Increased intramyocellular lipid droplets (HP:0012240) | 1.60878121 |
| 167 | Entropion (HP:0000621) | 1.59548402 |
| 168 | Stridor (HP:0010307) | 1.58980778 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.49435354 |
| 2 | BUB1 | 4.41943535 |
| 3 | TRIB3 | 3.98993484 |
| 4 | ERN1 | 3.90125533 |
| 5 | VRK2 | 3.72760623 |
| 6 | IRAK3 | 3.16618537 |
| 7 | PKN2 | 2.99355690 |
| 8 | ZAP70 | 2.76043136 |
| 9 | MAP4K1 | 2.53370708 |
| 10 | PBK | 2.26447358 |
| 11 | SRPK1 | 2.19268603 |
| 12 | BLK | 2.14138171 |
| 13 | FLT3 | 2.13319914 |
| 14 | TESK1 | 2.09961464 |
| 15 | SMG1 | 2.09946181 |
| 16 | TSSK6 | 2.07024039 |
| 17 | ZAK | 2.04187018 |
| 18 | TLK1 | 2.03790210 |
| 19 | RIPK1 | 2.03771465 |
| 20 | KDR | 1.94965348 |
| 21 | SCYL2 | 1.91223865 |
| 22 | LIMK1 | 1.81554045 |
| 23 | NME2 | 1.81010989 |
| 24 | NEK1 | 1.79474977 |
| 25 | EIF2AK3 | 1.76943035 |
| 26 | TAOK3 | 1.75227037 |
| 27 | NME1 | 1.72679562 |
| 28 | TTK | 1.70452972 |
| 29 | JAK3 | 1.66018415 |
| 30 | EEF2K | 1.60206531 |
| 31 | MST1R | 1.55619283 |
| 32 | TYK2 | 1.53831352 |
| 33 | JAK1 | 1.53483569 |
| 34 | CDC7 | 1.53136094 |
| 35 | TGFBR2 | 1.51359480 |
| 36 | TBK1 | 1.50278689 |
| 37 | MST4 | 1.46357591 |
| 38 | TESK2 | 1.40834506 |
| 39 | EPHA2 | 1.35950872 |
| 40 | MAP3K1 | 1.34890160 |
| 41 | MAP2K2 | 1.33928023 |
| 42 | MAP2K3 | 1.32826837 |
| 43 | KSR2 | 1.32247838 |
| 44 | KIT | 1.29803350 |
| 45 | FGFR4 | 1.29339668 |
| 46 | GRK6 | 1.28355380 |
| 47 | CDK7 | 1.27439793 |
| 48 | EIF2AK1 | 1.24215937 |
| 49 | MAPKAPK3 | 1.22931656 |
| 50 | STK16 | 1.20483878 |
| 51 | NLK | 1.17832960 |
| 52 | LRRK2 | 1.15962667 |
| 53 | ARAF | 1.14409449 |
| 54 | VRK1 | 1.14192664 |
| 55 | SIK1 | 1.12387738 |
| 56 | BTK | 1.07717521 |
| 57 | MET | 1.07126437 |
| 58 | JAK2 | 1.06045558 |
| 59 | PASK | 1.02955205 |
| 60 | IRAK4 | 1.02432198 |
| 61 | TAF1 | 0.99809846 |
| 62 | INSRR | 0.99746152 |
| 63 | BRSK2 | 0.97136381 |
| 64 | PTK6 | 0.96422277 |
| 65 | AURKA | 0.95469493 |
| 66 | CHEK2 | 0.95284041 |
| 67 | AURKB | 0.93917128 |
| 68 | EPHB1 | 0.92713831 |
| 69 | NEK2 | 0.92703440 |
| 70 | PLK1 | 0.92623917 |
| 71 | SYK | 0.92214265 |
| 72 | FES | 0.92005652 |
| 73 | ATR | 0.91830398 |
| 74 | HIPK2 | 0.91804642 |
| 75 | CSF1R | 0.91385384 |
| 76 | BRSK1 | 0.88065206 |
| 77 | PIM2 | 0.87444495 |
| 78 | MOS | 0.86312427 |
| 79 | PIK3CG | 0.83998284 |
| 80 | IKBKE | 0.83968461 |
| 81 | ERBB4 | 0.82398300 |
| 82 | TEC | 0.81690412 |
| 83 | MAP3K13 | 0.80783508 |
| 84 | PRKCI | 0.80681756 |
| 85 | MAPK15 | 0.80332733 |
| 86 | TXK | 0.79080830 |
| 87 | MAP3K11 | 0.76177125 |
| 88 | IRAK1 | 0.76115380 |
| 89 | RPS6KA5 | 0.75430294 |
| 90 | STK4 | 0.75021778 |
| 91 | NTRK1 | 0.72280929 |
| 92 | NEK9 | 0.71492313 |
| 93 | LYN | 0.70800538 |
| 94 | PLK3 | 0.69054089 |
| 95 | PDK1 | 0.68749262 |
| 96 | MAP3K2 | 0.67227095 |
| 97 | EIF2AK2 | 0.65843231 |
| 98 | CDK4 | 0.65480527 |
| 99 | PDPK1 | 0.63117571 |
| 100 | MAP3K10 | 0.62951905 |
| 101 | PLK4 | 0.62699600 |
| 102 | PRKCH | 0.62641423 |
| 103 | CAMKK2 | 0.62384266 |
| 104 | CDK8 | 0.62313493 |
| 105 | MAP2K1 | 0.62268916 |
| 106 | CLK1 | 0.62177177 |
| 107 | STK10 | 0.62162911 |
| 108 | IRAK2 | 0.61770372 |
| 109 | ABL2 | 0.61347770 |
| 110 | NUAK1 | 0.61094447 |
| 111 | LCK | 0.60244895 |
| 112 | ITK | 0.59800708 |
| 113 | MARK3 | 0.59774552 |
| 114 | RPS6KA4 | 0.57582951 |
| 115 | DAPK1 | 0.56933694 |
| 116 | BRAF | 0.56093708 |
| 117 | DYRK3 | 0.55734228 |
| 118 | WEE1 | 0.55382944 |
| 119 | MAPK12 | 0.54546679 |
| 120 | MAP3K9 | 0.53515380 |
| 121 | PAK1 | 0.53279217 |
| 122 | CHEK1 | 0.52511777 |
| 123 | RPS6KB2 | 0.50991274 |
| 124 | RAF1 | 0.50922145 |
| 125 | GRK1 | 0.50344402 |
| 126 | CSNK2A1 | 0.49477705 |
| 127 | MAP3K3 | 0.49271843 |
| 128 | MAP4K2 | 0.48847344 |
| 129 | PAK4 | 0.48129041 |
| 130 | TRIM28 | 0.47778752 |
| 131 | PDK2 | 0.47047826 |
| 132 | CSNK1G3 | 0.46533877 |
| 133 | MAPK11 | 0.45507960 |
| 134 | MAPKAPK5 | 0.45210200 |
| 135 | CDK12 | 0.44891692 |
| 136 | RET | 0.44681506 |
| 137 | IKBKB | 0.44612198 |
| 138 | PAK2 | 0.42106719 |
| 139 | WNK4 | 0.42040943 |
| 140 | ILK | 0.41667853 |
| 141 | PRKCD | 0.41125793 |
| 142 | HCK | 0.39760988 |
| 143 | TGFBR1 | 0.38515413 |
| 144 | ADRBK2 | 0.37446782 |
| 145 | CSK | 0.36361564 |
| 146 | MKNK1 | 0.34793420 |
| 147 | CSNK2A2 | 0.34771626 |
| 148 | RPS6KA2 | 0.34761497 |
| 149 | TNIK | 0.34393686 |
| 150 | PRKG2 | 0.34157140 |
| 151 | BRD4 | 0.34020407 |
| 152 | ALK | 0.33520657 |
| 153 | AKT2 | 0.33275204 |
| 154 | PTK2 | 0.32993705 |
| 155 | TTN | 0.32646991 |
| 156 | RIPK4 | 0.32559477 |
| 157 | CSNK1A1L | 0.31682532 |
| 158 | MATK | 0.31555441 |
| 159 | MAPKAPK2 | 0.31237596 |
| 160 | CAMKK1 | 0.31063337 |
| 161 | MAP3K8 | 0.29747694 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.27306221 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.08222426 |
| 3 | Protein export_Homo sapiens_hsa03060 | 2.86167249 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.73434350 |
| 5 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.64266497 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.56744511 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 2.52128120 |
| 8 | Sulfur relay system_Homo sapiens_hsa04122 | 2.38803164 |
| 9 | RNA polymerase_Homo sapiens_hsa03020 | 2.37440711 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.31494976 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.28104067 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.25610042 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.17531253 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.16808953 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 2.15503589 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.13246993 |
| 17 | Mismatch repair_Homo sapiens_hsa03430 | 2.08163921 |
| 18 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.08041830 |
| 19 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.07866758 |
| 20 | Lysosome_Homo sapiens_hsa04142 | 2.02979671 |
| 21 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.91843823 |
| 22 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.89307317 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.87886314 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.87358042 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.81989346 |
| 26 | Homologous recombination_Homo sapiens_hsa03440 | 1.81258541 |
| 27 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.80554823 |
| 28 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.76246368 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.67233367 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.62201406 |
| 31 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.60322198 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.59170423 |
| 33 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.58888151 |
| 34 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.58078651 |
| 35 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.57797827 |
| 36 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.55844372 |
| 37 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.52947091 |
| 38 | Galactose metabolism_Homo sapiens_hsa00052 | 1.50630274 |
| 39 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.47891407 |
| 40 | Spliceosome_Homo sapiens_hsa03040 | 1.45074374 |
| 41 | RNA transport_Homo sapiens_hsa03013 | 1.43333735 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.40370988 |
| 43 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.40341704 |
| 44 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.40092067 |
| 45 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.37643961 |
| 46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.34395931 |
| 47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.34303602 |
| 48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.31993989 |
| 49 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.31201569 |
| 50 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.31193577 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.31157143 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 1.27110015 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 1.25924982 |
| 54 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.25009058 |
| 55 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.24009640 |
| 56 | * N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.20609773 |
| 57 | Ribosome_Homo sapiens_hsa03010 | 1.19354835 |
| 58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.18849697 |
| 59 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.16538981 |
| 60 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.16299560 |
| 61 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.13791811 |
| 62 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.12652825 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.08427857 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.08405666 |
| 65 | Purine metabolism_Homo sapiens_hsa00230 | 1.08284383 |
| 66 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.07846413 |
| 67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.06676941 |
| 68 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.06216919 |
| 69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.99855460 |
| 70 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.99828070 |
| 71 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.94059458 |
| 72 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.93616188 |
| 73 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.92813671 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91934964 |
| 75 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.91128868 |
| 76 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.89068932 |
| 77 | Cell cycle_Homo sapiens_hsa04110 | 0.88101483 |
| 78 | Histidine metabolism_Homo sapiens_hsa00340 | 0.84579758 |
| 79 | Parkinsons disease_Homo sapiens_hsa05012 | 0.82344623 |
| 80 | Proteasome_Homo sapiens_hsa03050 | 0.74169465 |
| 81 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.72873516 |
| 82 | Bile secretion_Homo sapiens_hsa04976 | 0.70500241 |
| 83 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.69017532 |
| 84 | Huntingtons disease_Homo sapiens_hsa05016 | 0.67968028 |
| 85 | Basal transcription factors_Homo sapiens_hsa03022 | 0.67268043 |
| 86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.67208849 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.66252277 |
| 88 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.64279853 |
| 89 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.63911222 |
| 90 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.63503832 |
| 91 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.62671231 |
| 92 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.62524474 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62372343 |
| 94 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.62111982 |
| 95 | RNA degradation_Homo sapiens_hsa03018 | 0.61437107 |
| 96 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.61297011 |
| 97 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60713903 |
| 98 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60416483 |
| 99 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.60177008 |
| 100 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.59263945 |
| 101 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.59212621 |
| 102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56405724 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52652610 |
| 104 | Bladder cancer_Homo sapiens_hsa05219 | 0.52155451 |
| 105 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.51063147 |
| 106 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50898550 |
| 107 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50116387 |
| 108 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.45515542 |
| 109 | Insulin resistance_Homo sapiens_hsa04931 | 0.44435543 |
| 110 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.42388458 |
| 111 | Retinol metabolism_Homo sapiens_hsa00830 | 0.40867635 |
| 112 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.40136013 |
| 113 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.39976508 |
| 114 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37016276 |
| 115 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.32536712 |
| 116 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.32520135 |
| 117 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.31258441 |
| 118 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.31241309 |
| 119 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.30767281 |
| 120 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.30237494 |
| 121 | Alzheimers disease_Homo sapiens_hsa05010 | 0.30060713 |
| 122 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.28788889 |
| 123 | Shigellosis_Homo sapiens_hsa05131 | 0.28418582 |
| 124 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27070088 |
| 125 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.26847825 |
| 126 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.24300157 |
| 127 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.23467325 |
| 128 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.23074915 |
| 129 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22593270 |
| 130 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.22155585 |

